Chemoinformaics analysis of 2,5-Dimethylfuran
| Molecular Weight | 96.129 | nRot | 0 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 5 |
| Exact Molecular Weight | 96.0575 | nRing | 1 |
| Solubility: LogS | -1.72 | nHRing | 1 |
| Solubility: LogP | 2.15 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 16.1563 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.48 |
| Synth | 1.99 |
| Natural Product Likeliness | -0.503 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.054 |
| HIA | 0.004 |
| CACO-2 | -4.451 |
| MDCK | 0.0000198 |
| BBB | 0.554 |
| PPB | 0.832162 |
| VDSS | 3.525 |
| FU | 0.345382 |
| CYP1A2-inh | 0.904 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.547 |
| CYP2c19-sub | 0.92 |
| CYP2c9-inh | 0.054 |
| CYP2c9-sub | 0.724 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.892 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.531 |
| CL | 11.066 |
| T12 | 0.737 |
| hERG | 0.02 |
| Ames | 0.028 |
| ROA | 0.143 |
| SkinSen | 0.083 |
| Carcinogencity | 0.747 |
| EI | 0.991 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.935575 |